nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—atopic dermatitis	0.299	1	CpDpCtD
Caffeine—Fenethylline—Dimenhydrinate—atopic dermatitis	0.283	1	CrCrCtD
Caffeine—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0189	0.0722	CbGbCtD
Caffeine—CYP3A7—Tacrolimus—atopic dermatitis	0.0189	0.0722	CbGbCtD
Caffeine—CYP2C8—Mometasone—atopic dermatitis	0.0174	0.0664	CbGbCtD
Caffeine—CYP3A5—Tacrolimus—atopic dermatitis	0.0142	0.0542	CbGbCtD
Caffeine—CYP1B1—Dexamethasone—atopic dermatitis	0.0137	0.0521	CbGbCtD
Caffeine—CYP2C8—Loratadine—atopic dermatitis	0.00999	0.0381	CbGbCtD
Caffeine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00931	0.0355	CbGbCtD
Caffeine—ABCB1—Tacrolimus—atopic dermatitis	0.00924	0.0352	CbGbCtD
Caffeine—CYP1A2—Diphenhydramine—atopic dermatitis	0.00774	0.0295	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00771	0.0294	CbGbCtD
Caffeine—CYP3A7—Hydrocortisone—atopic dermatitis	0.00771	0.0294	CbGbCtD
Caffeine—CYP2C9—Loratadine—atopic dermatitis	0.00697	0.0266	CbGbCtD
Caffeine—CYP2C9—Diphenhydramine—atopic dermatitis	0.00697	0.0266	CbGbCtD
Caffeine—ABCB1—Loratadine—atopic dermatitis	0.00677	0.0258	CbGbCtD
Caffeine—CYP2D6—Loratadine—atopic dermatitis	0.00637	0.0243	CbGbCtD
Caffeine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00637	0.0243	CbGbCtD
Caffeine—ABCB1—Methylprednisolone—atopic dermatitis	0.00619	0.0236	CbGbCtD
Caffeine—CYP1A1—Dexamethasone—atopic dermatitis	0.00599	0.0228	CbGbCtD
Caffeine—CYP3A5—Hydrocortisone—atopic dermatitis	0.00578	0.0221	CbGbCtD
Caffeine—CYP2C8—Hydrocortisone—atopic dermatitis	0.00556	0.0212	CbGbCtD
Caffeine—CYP3A4—Tacrolimus—atopic dermatitis	0.00554	0.0211	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00479	0.0183	CbGbCtD
Caffeine—CYP3A7—Dexamethasone—atopic dermatitis	0.00479	0.0183	CbGbCtD
Caffeine—CYP2E1—Dexamethasone—atopic dermatitis	0.00463	0.0176	CbGbCtD
Caffeine—CYP3A4—Loratadine—atopic dermatitis	0.00405	0.0155	CbGbCtD
Caffeine—ABCB1—Betamethasone—atopic dermatitis	0.00402	0.0153	CbGbCtD
Caffeine—ABCB1—Prednisolone—atopic dermatitis	0.00397	0.0151	CbGbCtD
Caffeine—ABCB1—Hydrocortisone—atopic dermatitis	0.00376	0.0144	CbGbCtD
Caffeine—ABCB1—Prednisone—atopic dermatitis	0.00375	0.0143	CbGbCtD
Caffeine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00371	0.0141	CbGbCtD
Caffeine—CYP3A5—Dexamethasone—atopic dermatitis	0.0036	0.0137	CbGbCtD
Caffeine—PIK3CA—skin epidermis—atopic dermatitis	0.00351	0.164	CbGeAlD
Caffeine—Retinopathy of prematurity—Dexamethasone—atopic dermatitis	0.0035	0.0595	CcSEcCtD
Caffeine—Retinopathy of prematurity—Betamethasone—atopic dermatitis	0.0035	0.0595	CcSEcCtD
Caffeine—CYP2C8—Dexamethasone—atopic dermatitis	0.00346	0.0132	CbGbCtD
Caffeine—CYP3A4—Triamcinolone—atopic dermatitis	0.00281	0.0107	CbGbCtD
Caffeine—CYP2C9—Dexamethasone—atopic dermatitis	0.00241	0.0092	CbGbCtD
Caffeine—CYP3A4—Betamethasone—atopic dermatitis	0.00241	0.00919	CbGbCtD
Caffeine—CYP3A4—Prednisolone—atopic dermatitis	0.00238	0.00907	CbGbCtD
Caffeine—ABCB1—Dexamethasone—atopic dermatitis	0.00234	0.00892	CbGbCtD
Caffeine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00225	0.0086	CbGbCtD
Caffeine—CYP3A4—Prednisone—atopic dermatitis	0.00225	0.00857	CbGbCtD
Caffeine—CYP2D6—Dexamethasone—atopic dermatitis	0.00221	0.00841	CbGbCtD
Caffeine—PIK3CD—neck—atopic dermatitis	0.00195	0.0909	CbGeAlD
Caffeine—Ca++ increased—Methylprednisolone—atopic dermatitis	0.00185	0.0314	CcSEcCtD
Caffeine—PIK3CB—neck—atopic dermatitis	0.0017	0.0793	CbGeAlD
Caffeine—PIK3CA—neck—atopic dermatitis	0.00168	0.0785	CbGeAlD
Caffeine—ATM—skin of body—atopic dermatitis	0.00142	0.0663	CbGeAlD
Caffeine—CYP3A4—Dexamethasone—atopic dermatitis	0.0014	0.00535	CbGbCtD
Caffeine—PIK3CD—skin of body—atopic dermatitis	0.00126	0.0588	CbGeAlD
Caffeine—Impaired healing—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.0205	CcSEcCtD
Caffeine—Impaired healing—Mometasone—atopic dermatitis	0.00115	0.0195	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Tacrolimus—atopic dermatitis	0.00111	0.0188	CcSEcCtD
Caffeine—PIK3CB—skin of body—atopic dermatitis	0.0011	0.0513	CbGeAlD
Caffeine—PIK3CA—skin of body—atopic dermatitis	0.00109	0.0508	CbGeAlD
Caffeine—Feeling jittery—Tacrolimus—atopic dermatitis	0.00106	0.0181	CcSEcCtD
Caffeine—ATM—head—atopic dermatitis	0.000928	0.0433	CbGeAlD
Caffeine—Impaired healing—Tacrolimus—atopic dermatitis	0.000915	0.0155	CcSEcCtD
Caffeine—CYP1A1—skin epidermis—atopic dermatitis	0.000832	0.0388	CbGeAlD
Caffeine—PIK3CD—head—atopic dermatitis	0.000823	0.0384	CbGeAlD
Caffeine—PIK3CB—head—atopic dermatitis	0.000718	0.0335	CbGeAlD
Caffeine—Cerebral haemorrhage—Tacrolimus—atopic dermatitis	0.000715	0.0121	CcSEcCtD
Caffeine—Acidosis—Tacrolimus—atopic dermatitis	0.000715	0.0121	CcSEcCtD
Caffeine—Irritability—Desonide—atopic dermatitis	0.000713	0.0121	CcSEcCtD
Caffeine—RYR1—head—atopic dermatitis	0.00071	0.0331	CbGeAlD
Caffeine—PIK3CA—head—atopic dermatitis	0.00071	0.0331	CbGeAlD
Caffeine—Impaired healing—Prednisolone—atopic dermatitis	0.000584	0.00993	CcSEcCtD
Caffeine—Hyperglycaemia—Desonide—atopic dermatitis	0.000583	0.0099	CcSEcCtD
Caffeine—Infestation NOS—Desonide—atopic dermatitis	0.000576	0.00979	CcSEcCtD
Caffeine—Infestation—Desonide—atopic dermatitis	0.000576	0.00979	CcSEcCtD
Caffeine—Impaired healing—Hydrocortisone—atopic dermatitis	0.000571	0.0097	CcSEcCtD
Caffeine—Hypercalcaemia—Tacrolimus—atopic dermatitis	0.00057	0.00968	CcSEcCtD
Caffeine—Dry skin—Fluocinonide—atopic dermatitis	0.000555	0.00943	CcSEcCtD
Caffeine—Impaired healing—Triamcinolone—atopic dermatitis	0.000537	0.00913	CcSEcCtD
Caffeine—Impaired healing—Methylprednisolone—atopic dermatitis	0.000536	0.00911	CcSEcCtD
Caffeine—ADORA2B—head—atopic dermatitis	0.000522	0.0244	CbGeAlD
Caffeine—Irritability—Diphenhydramine—atopic dermatitis	0.000521	0.00886	CcSEcCtD
Caffeine—Irritability—Dimenhydrinate—atopic dermatitis	0.000521	0.00886	CcSEcCtD
Caffeine—Impaired healing—Betamethasone—atopic dermatitis	0.000488	0.00829	CcSEcCtD
Caffeine—Impaired healing—Dexamethasone—atopic dermatitis	0.000488	0.00829	CcSEcCtD
Caffeine—Hyperglycaemia—Fluocinonide—atopic dermatitis	0.000472	0.00802	CcSEcCtD
Caffeine—Accidental injury—Tacrolimus—atopic dermatitis	0.000447	0.0076	CcSEcCtD
Caffeine—ADORA2A—head—atopic dermatitis	0.000435	0.0203	CbGeAlD
Caffeine—Impaired healing—Prednisone—atopic dermatitis	0.000425	0.00722	CcSEcCtD
Caffeine—Creatinine increased—Tacrolimus—atopic dermatitis	0.000416	0.00706	CcSEcCtD
Caffeine—Infestation NOS—Pimecrolimus—atopic dermatitis	0.000407	0.00691	CcSEcCtD
Caffeine—Infestation—Pimecrolimus—atopic dermatitis	0.000407	0.00691	CcSEcCtD
Caffeine—Injury—Mometasone—atopic dermatitis	0.000393	0.00667	CcSEcCtD
Caffeine—Hypoglycaemia—Fluocinolone Acetonide—atopic dermatitis	0.000387	0.00658	CcSEcCtD
Caffeine—Immune system disorder—Fluocinonide—atopic dermatitis	0.000378	0.00643	CcSEcCtD
Caffeine—ADORA1—head—atopic dermatitis	0.000375	0.0175	CbGeAlD
Caffeine—Gastritis—Loratadine—atopic dermatitis	0.000372	0.00633	CcSEcCtD
Caffeine—Infection—Desonide—atopic dermatitis	0.000365	0.0062	CcSEcCtD
Caffeine—CYP1B1—skin of body—atopic dermatitis	0.000365	0.017	CbGeAlD
Caffeine—Nervous system disorder—Desonide—atopic dermatitis	0.00036	0.00612	CcSEcCtD
Caffeine—Skin disorder—Desonide—atopic dermatitis	0.000357	0.00606	CcSEcCtD
Caffeine—Pulmonary oedema—Tacrolimus—atopic dermatitis	0.000352	0.00599	CcSEcCtD
Caffeine—Sepsis—Tacrolimus—atopic dermatitis	0.000343	0.00584	CcSEcCtD
Caffeine—Hypercalcaemia—Methylprednisolone—atopic dermatitis	0.000334	0.00567	CcSEcCtD
Caffeine—PRKDC—Testosterone—Hydrocortisone—atopic dermatitis	0.000333	0.214	CbGdCrCtD
Caffeine—Immune system disorder—Pimecrolimus—atopic dermatitis	0.00033	0.00561	CcSEcCtD
Caffeine—Deafness—Tacrolimus—atopic dermatitis	0.000321	0.00546	CcSEcCtD
Caffeine—Nervousness—Diphenhydramine—atopic dermatitis	0.000319	0.00543	CcSEcCtD
Caffeine—Nervousness—Dimenhydrinate—atopic dermatitis	0.000319	0.00543	CcSEcCtD
Caffeine—Malnutrition—Pimecrolimus—atopic dermatitis	0.000318	0.0054	CcSEcCtD
Caffeine—Injury—Tacrolimus—atopic dermatitis	0.000313	0.00531	CcSEcCtD
Caffeine—Agitation—Diphenhydramine—atopic dermatitis	0.000302	0.00514	CcSEcCtD
Caffeine—Agitation—Dimenhydrinate—atopic dermatitis	0.000302	0.00514	CcSEcCtD
Caffeine—Infection—Fluocinonide—atopic dermatitis	0.000296	0.00503	CcSEcCtD
Caffeine—Hypoglycaemia—Tacrolimus—atopic dermatitis	0.000294	0.005	CcSEcCtD
Caffeine—Nervous system disorder—Fluocinonide—atopic dermatitis	0.000292	0.00496	CcSEcCtD
Caffeine—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.000291	0.00495	CcSEcCtD
Caffeine—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.000291	0.00495	CcSEcCtD
Caffeine—Skin disorder—Fluocinonide—atopic dermatitis	0.000289	0.00491	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Tacrolimus—atopic dermatitis	0.000287	0.00488	CcSEcCtD
Caffeine—Convulsion—Dimenhydrinate—atopic dermatitis	0.000285	0.00484	CcSEcCtD
Caffeine—Convulsion—Diphenhydramine—atopic dermatitis	0.000285	0.00484	CcSEcCtD
Caffeine—PRKDC—Testosterone—Prednisolone—atopic dermatitis	0.00028	0.18	CbGdCrCtD
Caffeine—PDE4B—head—atopic dermatitis	0.000278	0.013	CbGeAlD
Caffeine—PRKDC—Danazol—Hydrocortisone—atopic dermatitis	0.000271	0.174	CbGdCrCtD
Caffeine—Blood creatinine increased—Tacrolimus—atopic dermatitis	0.000269	0.00457	CcSEcCtD
Caffeine—Dry skin—Tacrolimus—atopic dermatitis	0.000263	0.00447	CcSEcCtD
Caffeine—Immune system disorder—Loratadine—atopic dermatitis	0.000263	0.00447	CcSEcCtD
Caffeine—Tachycardia—Diphenhydramine—atopic dermatitis	0.000262	0.00445	CcSEcCtD
Caffeine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.000262	0.00445	CcSEcCtD
Caffeine—CYP1A1—skin of body—atopic dermatitis	0.000258	0.012	CbGeAlD
Caffeine—Infection—Pimecrolimus—atopic dermatitis	0.000258	0.00438	CcSEcCtD
Caffeine—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000254	0.00432	CcSEcCtD
Caffeine—Gastritis—Tacrolimus—atopic dermatitis	0.000254	0.00432	CcSEcCtD
Caffeine—Skin disorder—Pimecrolimus—atopic dermatitis	0.000252	0.00428	CcSEcCtD
Caffeine—Nervousness—Loratadine—atopic dermatitis	0.000246	0.00418	CcSEcCtD
Caffeine—PRKDC—Norethindrone—Hydrocortisone—atopic dermatitis	0.000244	0.157	CbGdCrCtD
Caffeine—CYP1B1—head—atopic dermatitis	0.000238	0.0111	CbGeAlD
Caffeine—PRKDC—Danazol—Prednisone—atopic dermatitis	0.000233	0.15	CbGdCrCtD
Caffeine—Agitation—Loratadine—atopic dermatitis	0.000233	0.00396	CcSEcCtD
Caffeine—Rash—Desonide—atopic dermatitis	0.000232	0.00394	CcSEcCtD
Caffeine—Dermatitis—Desonide—atopic dermatitis	0.000231	0.00393	CcSEcCtD
Caffeine—Dyspnoea—Pimecrolimus—atopic dermatitis	0.000231	0.00393	CcSEcCtD
Caffeine—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.000228	0.00387	CcSEcCtD
Caffeine—Immune system disorder—Mometasone—atopic dermatitis	0.000226	0.00383	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisolone—atopic dermatitis	0.000225	0.00382	CcSEcCtD
Caffeine—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000224	0.00381	CcSEcCtD
Caffeine—Hyperglycaemia—Tacrolimus—atopic dermatitis	0.000224	0.00381	CcSEcCtD
Caffeine—Infestation NOS—Tacrolimus—atopic dermatitis	0.000221	0.00376	CcSEcCtD
Caffeine—Infestation—Tacrolimus—atopic dermatitis	0.000221	0.00376	CcSEcCtD
Caffeine—Pulmonary oedema—Hydrocortisone—atopic dermatitis	0.00022	0.00373	CcSEcCtD
Caffeine—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000219	0.00373	CcSEcCtD
Caffeine—Hypertension—Loratadine—atopic dermatitis	0.000219	0.00372	CcSEcCtD
Caffeine—Renal failure—Tacrolimus—atopic dermatitis	0.000218	0.0037	CcSEcCtD
Caffeine—Pulmonary oedema—Triamcinolone—atopic dermatitis	0.000207	0.00352	CcSEcCtD
Caffeine—Pulmonary oedema—Methylprednisolone—atopic dermatitis	0.000206	0.00351	CcSEcCtD
Caffeine—Nervous system disorder—Loratadine—atopic dermatitis	0.000203	0.00344	CcSEcCtD
Caffeine—Tachycardia—Loratadine—atopic dermatitis	0.000202	0.00343	CcSEcCtD
Caffeine—Skin disorder—Loratadine—atopic dermatitis	0.000201	0.00341	CcSEcCtD
Caffeine—Haemoglobin—Tacrolimus—atopic dermatitis	0.0002	0.00339	CcSEcCtD
Caffeine—Injury—Prednisolone—atopic dermatitis	0.0002	0.00339	CcSEcCtD
Caffeine—Haemorrhage—Tacrolimus—atopic dermatitis	0.000199	0.00338	CcSEcCtD
Caffeine—Injury—Hydrocortisone—atopic dermatitis	0.000195	0.00331	CcSEcCtD
Caffeine—PRKDC—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000194	0.125	CbGdCrCtD
Caffeine—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000191	0.00325	CcSEcCtD
Caffeine—Pulmonary oedema—Betamethasone—atopic dermatitis	0.000188	0.00319	CcSEcCtD
Caffeine—Pulmonary oedema—Dexamethasone—atopic dermatitis	0.000188	0.00319	CcSEcCtD
Caffeine—Rash—Fluocinonide—atopic dermatitis	0.000188	0.00319	CcSEcCtD
Caffeine—Dermatitis—Fluocinonide—atopic dermatitis	0.000188	0.00319	CcSEcCtD
Caffeine—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000185	0.00314	CcSEcCtD
Caffeine—Cardiac disorder—Tacrolimus—atopic dermatitis	0.000184	0.00313	CcSEcCtD
Caffeine—Injury—Triamcinolone—atopic dermatitis	0.000184	0.00312	CcSEcCtD
Caffeine—Injury—Methylprednisolone—atopic dermatitis	0.000183	0.00311	CcSEcCtD
Caffeine—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000182	0.0031	CcSEcCtD
Caffeine—Immune system disorder—Tacrolimus—atopic dermatitis	0.000179	0.00305	CcSEcCtD
Caffeine—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000178	0.00303	CcSEcCtD
Caffeine—Infection—Mometasone—atopic dermatitis	0.000176	0.00299	CcSEcCtD
Caffeine—Malnutrition—Tacrolimus—atopic dermatitis	0.000173	0.00294	CcSEcCtD
Caffeine—Irritability—Hydrocortisone—atopic dermatitis	0.000171	0.00291	CcSEcCtD
Caffeine—Rash—Dimenhydrinate—atopic dermatitis	0.000169	0.00288	CcSEcCtD
Caffeine—Rash—Diphenhydramine—atopic dermatitis	0.000169	0.00288	CcSEcCtD
Caffeine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000169	0.00287	CcSEcCtD
Caffeine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000169	0.00287	CcSEcCtD
Caffeine—CYP1A1—head—atopic dermatitis	0.000168	0.00785	CbGeAlD
Caffeine—Dry skin—Prednisolone—atopic dermatitis	0.000168	0.00286	CcSEcCtD
Caffeine—Nervousness—Tacrolimus—atopic dermatitis	0.000168	0.00286	CcSEcCtD
Caffeine—Injury—Dexamethasone—atopic dermatitis	0.000167	0.00283	CcSEcCtD
Caffeine—Injury—Betamethasone—atopic dermatitis	0.000167	0.00283	CcSEcCtD
Caffeine—Dry skin—Hydrocortisone—atopic dermatitis	0.000164	0.00279	CcSEcCtD
Caffeine—Rash—Pimecrolimus—atopic dermatitis	0.000164	0.00278	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisone—atopic dermatitis	0.000163	0.00278	CcSEcCtD
Caffeine—Dermatitis—Pimecrolimus—atopic dermatitis	0.000163	0.00278	CcSEcCtD
Caffeine—Irritability—Methylprednisolone—atopic dermatitis	0.000161	0.00273	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00016	0.00273	CcSEcCtD
Caffeine—Sepsis—Prednisone—atopic dermatitis	0.000159	0.00271	CcSEcCtD
Caffeine—Agitation—Tacrolimus—atopic dermatitis	0.000159	0.0027	CcSEcCtD
Caffeine—Dyspnoea—Mometasone—atopic dermatitis	0.000158	0.00269	CcSEcCtD
Caffeine—CYP2E1—head—atopic dermatitis	0.000153	0.00716	CbGeAlD
Caffeine—Convulsion—Tacrolimus—atopic dermatitis	0.00015	0.00255	CcSEcCtD
Caffeine—Hypertension—Tacrolimus—atopic dermatitis	0.000149	0.00254	CcSEcCtD
Caffeine—Irritability—Dexamethasone—atopic dermatitis	0.000146	0.00248	CcSEcCtD
Caffeine—Irritability—Betamethasone—atopic dermatitis	0.000146	0.00248	CcSEcCtD
Caffeine—Injury—Prednisone—atopic dermatitis	0.000145	0.00247	CcSEcCtD
Caffeine—Dry skin—Betamethasone—atopic dermatitis	0.00014	0.00238	CcSEcCtD
Caffeine—Dry skin—Dexamethasone—atopic dermatitis	0.00014	0.00238	CcSEcCtD
Caffeine—Infection—Tacrolimus—atopic dermatitis	0.00014	0.00238	CcSEcCtD
Caffeine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000138	0.00235	CcSEcCtD
Caffeine—Infestation—Hydrocortisone—atopic dermatitis	0.000138	0.00235	CcSEcCtD
Caffeine—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000138	0.00235	CcSEcCtD
Caffeine—Tachycardia—Tacrolimus—atopic dermatitis	0.000138	0.00234	CcSEcCtD
Caffeine—Skin disorder—Tacrolimus—atopic dermatitis	0.000137	0.00233	CcSEcCtD
Caffeine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000137	0.00233	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000133	0.00227	CcSEcCtD
Caffeine—Rash—Loratadine—atopic dermatitis	0.00013	0.00221	CcSEcCtD
Caffeine—Dermatitis—Loratadine—atopic dermatitis	0.00013	0.00221	CcSEcCtD
Caffeine—Infestation NOS—Methylprednisolone—atopic dermatitis	0.00013	0.0022	CcSEcCtD
Caffeine—Infestation—Methylprednisolone—atopic dermatitis	0.00013	0.0022	CcSEcCtD
Caffeine—Haemoglobin—Prednisolone—atopic dermatitis	0.000128	0.00217	CcSEcCtD
Caffeine—Irritability—Prednisone—atopic dermatitis	0.000127	0.00216	CcSEcCtD
Caffeine—Haemorrhage—Prednisolone—atopic dermatitis	0.000127	0.00216	CcSEcCtD
Caffeine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000126	0.00214	CcSEcCtD
Caffeine—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000125	0.00212	CcSEcCtD
Caffeine—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000124	0.00211	CcSEcCtD
Caffeine—Dry skin—Prednisone—atopic dermatitis	0.000122	0.00208	CcSEcCtD
Caffeine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000122	0.00207	CcSEcCtD
Caffeine—CYP2D6—head—atopic dermatitis	0.000121	0.00567	CbGeAlD
Caffeine—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000119	0.00203	CcSEcCtD
Caffeine—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000119	0.00203	CcSEcCtD
Caffeine—Haemoglobin—Triamcinolone—atopic dermatitis	0.000117	0.00199	CcSEcCtD
Caffeine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000117	0.00199	CcSEcCtD
Caffeine—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000117	0.00199	CcSEcCtD
Caffeine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000117	0.00199	CcSEcCtD
Caffeine—Haemorrhage—Triamcinolone—atopic dermatitis	0.000117	0.00198	CcSEcCtD
Caffeine—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000116	0.00198	CcSEcCtD
Caffeine—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000112	0.0019	CcSEcCtD
Caffeine—Rash—Mometasone—atopic dermatitis	0.000112	0.0019	CcSEcCtD
Caffeine—Dermatitis—Mometasone—atopic dermatitis	0.000112	0.0019	CcSEcCtD
Caffeine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000108	0.00184	CcSEcCtD
Caffeine—Malnutrition—Hydrocortisone—atopic dermatitis	0.000108	0.00183	CcSEcCtD
Caffeine—Haemoglobin—Dexamethasone—atopic dermatitis	0.000106	0.00181	CcSEcCtD
Caffeine—Haemoglobin—Betamethasone—atopic dermatitis	0.000106	0.00181	CcSEcCtD
Caffeine—Haemorrhage—Dexamethasone—atopic dermatitis	0.000106	0.0018	CcSEcCtD
Caffeine—Haemorrhage—Betamethasone—atopic dermatitis	0.000106	0.0018	CcSEcCtD
Caffeine—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000105	0.00179	CcSEcCtD
Caffeine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000104	0.00177	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—atopic dermatitis	0.000104	0.00177	CcSEcCtD
Caffeine—Malnutrition—Methylprednisolone—atopic dermatitis	0.000101	0.00172	CcSEcCtD
Caffeine—Convulsion—Prednisolone—atopic dermatitis	9.57e-05	0.00163	CcSEcCtD
Caffeine—Hypertension—Prednisolone—atopic dermatitis	9.54e-05	0.00162	CcSEcCtD
Caffeine—Convulsion—Hydrocortisone—atopic dermatitis	9.35e-05	0.00159	CcSEcCtD
Caffeine—Hypertension—Hydrocortisone—atopic dermatitis	9.32e-05	0.00158	CcSEcCtD
Caffeine—Haemoglobin—Prednisone—atopic dermatitis	9.27e-05	0.00158	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—atopic dermatitis	9.22e-05	0.00157	CcSEcCtD
Caffeine—Rash—Tacrolimus—atopic dermatitis	8.9e-05	0.00151	CcSEcCtD
Caffeine—Dermatitis—Tacrolimus—atopic dermatitis	8.89e-05	0.00151	CcSEcCtD
Caffeine—Convulsion—Triamcinolone—atopic dermatitis	8.8e-05	0.0015	CcSEcCtD
Caffeine—Tachycardia—Prednisolone—atopic dermatitis	8.8e-05	0.0015	CcSEcCtD
Caffeine—Convulsion—Methylprednisolone—atopic dermatitis	8.78e-05	0.00149	CcSEcCtD
Caffeine—Hypertension—Triamcinolone—atopic dermatitis	8.77e-05	0.00149	CcSEcCtD
Caffeine—Hypertension—Methylprednisolone—atopic dermatitis	8.75e-05	0.00149	CcSEcCtD
Caffeine—Infection—Hydrocortisone—atopic dermatitis	8.75e-05	0.00149	CcSEcCtD
Caffeine—ABCB1—head—atopic dermatitis	8.74e-05	0.00408	CbGeAlD
Caffeine—Nervous system disorder—Hydrocortisone—atopic dermatitis	8.64e-05	0.00147	CcSEcCtD
Caffeine—Tachycardia—Hydrocortisone—atopic dermatitis	8.6e-05	0.00146	CcSEcCtD
Caffeine—Skin disorder—Hydrocortisone—atopic dermatitis	8.55e-05	0.00145	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—atopic dermatitis	8.33e-05	0.00142	CcSEcCtD
Caffeine—Infection—Triamcinolone—atopic dermatitis	8.24e-05	0.0014	CcSEcCtD
Caffeine—Infection—Methylprednisolone—atopic dermatitis	8.22e-05	0.0014	CcSEcCtD
Caffeine—Nervous system disorder—Methylprednisolone—atopic dermatitis	8.11e-05	0.00138	CcSEcCtD
Caffeine—Tachycardia—Triamcinolone—atopic dermatitis	8.09e-05	0.00138	CcSEcCtD
Caffeine—Tachycardia—Methylprednisolone—atopic dermatitis	8.08e-05	0.00137	CcSEcCtD
Caffeine—Skin disorder—Methylprednisolone—atopic dermatitis	8.04e-05	0.00137	CcSEcCtD
Caffeine—Malnutrition—Prednisone—atopic dermatitis	8.03e-05	0.00136	CcSEcCtD
Caffeine—Convulsion—Dexamethasone—atopic dermatitis	7.99e-05	0.00136	CcSEcCtD
Caffeine—Convulsion—Betamethasone—atopic dermatitis	7.99e-05	0.00136	CcSEcCtD
Caffeine—Hypertension—Dexamethasone—atopic dermatitis	7.96e-05	0.00135	CcSEcCtD
Caffeine—Hypertension—Betamethasone—atopic dermatitis	7.96e-05	0.00135	CcSEcCtD
Caffeine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.6e-05	0.00129	CcSEcCtD
Caffeine—Infection—Dexamethasone—atopic dermatitis	7.48e-05	0.00127	CcSEcCtD
Caffeine—Infection—Betamethasone—atopic dermatitis	7.48e-05	0.00127	CcSEcCtD
Caffeine—Dyspnoea—Triamcinolone—atopic dermatitis	7.39e-05	0.00126	CcSEcCtD
Caffeine—Nervous system disorder—Betamethasone—atopic dermatitis	7.38e-05	0.00125	CcSEcCtD
Caffeine—Nervous system disorder—Dexamethasone—atopic dermatitis	7.38e-05	0.00125	CcSEcCtD
Caffeine—Agitation—Prednisone—atopic dermatitis	7.38e-05	0.00125	CcSEcCtD
Caffeine—Tachycardia—Betamethasone—atopic dermatitis	7.34e-05	0.00125	CcSEcCtD
Caffeine—Tachycardia—Dexamethasone—atopic dermatitis	7.34e-05	0.00125	CcSEcCtD
Caffeine—Convulsion—Prednisone—atopic dermatitis	6.96e-05	0.00118	CcSEcCtD
Caffeine—Hypertension—Prednisone—atopic dermatitis	6.93e-05	0.00118	CcSEcCtD
Caffeine—Hypersensitivity—Prednisolone—atopic dermatitis	6.64e-05	0.00113	CcSEcCtD
Caffeine—Infection—Prednisone—atopic dermatitis	6.51e-05	0.00111	CcSEcCtD
Caffeine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.5e-05	0.0011	CcSEcCtD
Caffeine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.5e-05	0.0011	CcSEcCtD
Caffeine—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.49e-05	0.0011	CcSEcCtD
Caffeine—Nervous system disorder—Prednisone—atopic dermatitis	6.43e-05	0.00109	CcSEcCtD
Caffeine—Tachycardia—Prednisone—atopic dermatitis	6.4e-05	0.00109	CcSEcCtD
Caffeine—Skin disorder—Prednisone—atopic dermatitis	6.37e-05	0.00108	CcSEcCtD
Caffeine—Hypersensitivity—Triamcinolone—atopic dermatitis	6.11e-05	0.00104	CcSEcCtD
Caffeine—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.1e-05	0.00104	CcSEcCtD
Caffeine—Rash—Prednisolone—atopic dermatitis	5.69e-05	0.000966	CcSEcCtD
Caffeine—Dermatitis—Prednisolone—atopic dermatitis	5.68e-05	0.000965	CcSEcCtD
Caffeine—Rash—Hydrocortisone—atopic dermatitis	5.55e-05	0.000944	CcSEcCtD
Caffeine—Dermatitis—Hydrocortisone—atopic dermatitis	5.55e-05	0.000943	CcSEcCtD
Caffeine—Rash—Triamcinolone—atopic dermatitis	5.23e-05	0.000889	CcSEcCtD
Caffeine—Dermatitis—Triamcinolone—atopic dermatitis	5.22e-05	0.000888	CcSEcCtD
Caffeine—Rash—Methylprednisolone—atopic dermatitis	5.22e-05	0.000887	CcSEcCtD
Caffeine—Dermatitis—Methylprednisolone—atopic dermatitis	5.21e-05	0.000886	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—atopic dermatitis	4.83e-05	0.00082	CcSEcCtD
Caffeine—Rash—Betamethasone—atopic dermatitis	4.74e-05	0.000806	CcSEcCtD
Caffeine—Rash—Dexamethasone—atopic dermatitis	4.74e-05	0.000806	CcSEcCtD
Caffeine—Dermatitis—Betamethasone—atopic dermatitis	4.74e-05	0.000806	CcSEcCtD
Caffeine—Dermatitis—Dexamethasone—atopic dermatitis	4.74e-05	0.000806	CcSEcCtD
Caffeine—Rash—Prednisone—atopic dermatitis	4.13e-05	0.000702	CcSEcCtD
Caffeine—Dermatitis—Prednisone—atopic dermatitis	4.13e-05	0.000702	CcSEcCtD
Caffeine—ADORA2B—Signaling Pathways—NPS—atopic dermatitis	1.33e-05	0.00018	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—MAPK8—atopic dermatitis	1.33e-05	0.00018	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KIF3A—atopic dermatitis	1.33e-05	0.00018	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.33e-05	0.00018	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL1B—atopic dermatitis	1.33e-05	0.00018	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL2—atopic dermatitis	1.33e-05	0.000179	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—CD4—atopic dermatitis	1.32e-05	0.000179	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CASP8—atopic dermatitis	1.32e-05	0.000179	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCR3—atopic dermatitis	1.32e-05	0.000178	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CCL5—atopic dermatitis	1.31e-05	0.000177	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by NGF—IL6—atopic dermatitis	1.31e-05	0.000177	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCR3—atopic dermatitis	1.31e-05	0.000177	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CCR5—atopic dermatitis	1.3e-05	0.000176	CbGpPWpGaD
Caffeine—PIK3CA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.3e-05	0.000175	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CCL5—atopic dermatitis	1.29e-05	0.000175	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.29e-05	0.000175	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ADSL—atopic dermatitis	1.29e-05	0.000174	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CCR5—atopic dermatitis	1.28e-05	0.000174	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCR3—atopic dermatitis	1.27e-05	0.000172	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.26e-05	0.000171	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.26e-05	0.000171	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCR3—atopic dermatitis	1.26e-05	0.00017	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL5—atopic dermatitis	1.25e-05	0.000169	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—NFKBIA—atopic dermatitis	1.24e-05	0.000168	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL5—atopic dermatitis	1.24e-05	0.000168	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CCL5—atopic dermatitis	1.23e-05	0.000166	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL10—atopic dermatitis	1.22e-05	0.000165	CbGpPWpGaD
Caffeine—PRKDC—Immune System—MAPK8—atopic dermatitis	1.22e-05	0.000165	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CCR5—atopic dermatitis	1.22e-05	0.000164	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.21e-05	0.000164	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL11—atopic dermatitis	1.2e-05	0.000163	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CMA1—atopic dermatitis	1.2e-05	0.000163	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCR3—atopic dermatitis	1.19e-05	0.000161	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.19e-05	0.00016	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CCR5—atopic dermatitis	1.18e-05	0.00016	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CCR5—atopic dermatitis	1.18e-05	0.00016	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.17e-05	0.000159	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—MAPK8—atopic dermatitis	1.17e-05	0.000158	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CCR5—atopic dermatitis	1.17e-05	0.000158	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.16e-05	0.000157	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TAC1—atopic dermatitis	1.13e-05	0.000153	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NPS—atopic dermatitis	1.13e-05	0.000153	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT6—atopic dermatitis	1.13e-05	0.000153	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—IL6—atopic dermatitis	1.13e-05	0.000153	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CASP8—atopic dermatitis	1.12e-05	0.000152	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TAC1—atopic dermatitis	1.12e-05	0.000151	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NPS—atopic dermatitis	1.12e-05	0.000151	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL18—atopic dermatitis	1.12e-05	0.000151	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CCL5—atopic dermatitis	1.11e-05	0.000151	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCR3—atopic dermatitis	1.11e-05	0.00015	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—IL2—atopic dermatitis	1.11e-05	0.00015	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	1.11e-05	0.00015	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CCR5—atopic dermatitis	1.1e-05	0.000149	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD8A—atopic dermatitis	1.1e-05	0.000149	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCR3—atopic dermatitis	1.1e-05	0.000149	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000147	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CD4—atopic dermatitis	1.09e-05	0.000147	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NFKBIA—atopic dermatitis	1.08e-05	0.000147	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.07e-05	0.000145	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—CXCL8—atopic dermatitis	1.07e-05	0.000145	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL10—atopic dermatitis	1.07e-05	0.000144	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TAC1—atopic dermatitis	1.06e-05	0.000143	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NPS—atopic dermatitis	1.06e-05	0.000143	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.06e-05	0.000143	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL5—atopic dermatitis	1.05e-05	0.000143	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCL5—atopic dermatitis	1.05e-05	0.000142	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.05e-05	0.000142	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD4—atopic dermatitis	1.04e-05	0.000141	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL5—atopic dermatitis	1.04e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—IL6—atopic dermatitis	1.03e-05	0.000139	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.03e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—IL2—atopic dermatitis	1.02e-05	0.000138	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.02e-05	0.000138	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.01e-05	0.000137	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1e-05	0.000136	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL5—atopic dermatitis	9.86e-06	0.000133	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCR3—atopic dermatitis	9.82e-06	0.000133	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.79e-06	0.000132	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CASP8—atopic dermatitis	9.79e-06	0.000132	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NGF—atopic dermatitis	9.76e-06	0.000132	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CXCL8—atopic dermatitis	9.72e-06	0.000131	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IFNG—atopic dermatitis	9.55e-06	0.000129	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCR5—atopic dermatitis	9.49e-06	0.000128	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PPARA—atopic dermatitis	9.49e-06	0.000128	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.46e-06	0.000128	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CXCL8—atopic dermatitis	9.32e-06	0.000126	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CCR5—atopic dermatitis	9.31e-06	0.000126	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL2—atopic dermatitis	9.28e-06	0.000126	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	9.24e-06	0.000125	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD4—atopic dermatitis	9.22e-06	0.000125	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—MAPK8—atopic dermatitis	9.21e-06	0.000124	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	9.2e-06	0.000124	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCL5—atopic dermatitis	9.18e-06	0.000124	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CCR5—atopic dermatitis	9.11e-06	0.000123	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCL5—atopic dermatitis	9.1e-06	0.000123	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL10—atopic dermatitis	8.99e-06	0.000122	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—IL2—atopic dermatitis	8.91e-06	0.00012	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL10—atopic dermatitis	8.88e-06	0.00012	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—IL2—atopic dermatitis	8.83e-06	0.000119	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GLB1—atopic dermatitis	8.78e-06	0.000119	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GLB1—atopic dermatitis	8.76e-06	0.000118	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TAC1—atopic dermatitis	8.76e-06	0.000118	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NPS—atopic dermatitis	8.76e-06	0.000118	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCR3—atopic dermatitis	8.59e-06	0.000116	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—IL6—atopic dermatitis	8.56e-06	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NFKBIA—atopic dermatitis	8.55e-06	0.000116	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1B—atopic dermatitis	8.52e-06	0.000115	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CD4—atopic dermatitis	8.51e-06	0.000115	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—IL6—atopic dermatitis	8.51e-06	0.000115	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NGF—atopic dermatitis	8.51e-06	0.000115	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL2—atopic dermatitis	8.48e-06	0.000115	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CXCL8—atopic dermatitis	8.47e-06	0.000114	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NGF—atopic dermatitis	8.43e-06	0.000114	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ADSL—atopic dermatitis	8.42e-06	0.000114	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL10—atopic dermatitis	8.41e-06	0.000114	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ADSL—atopic dermatitis	8.4e-06	0.000114	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CXCL8—atopic dermatitis	8.39e-06	0.000113	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IFNG—atopic dermatitis	8.32e-06	0.000112	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GLB1—atopic dermatitis	8.28e-06	0.000112	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCR5—atopic dermatitis	8.27e-06	0.000112	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCR5—atopic dermatitis	8.2e-06	0.000111	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL5—atopic dermatitis	8.14e-06	0.00011	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL2—atopic dermatitis	8.09e-06	0.000109	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NFKBIA—atopic dermatitis	8.05e-06	0.000109	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD4—atopic dermatitis	8.04e-06	0.000109	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL2—atopic dermatitis	8.02e-06	0.000108	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ADSL—atopic dermatitis	7.94e-06	0.000107	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.86e-06	0.000106	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—MAPK8—atopic dermatitis	7.81e-06	0.000106	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL6—atopic dermatitis	7.79e-06	0.000105	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.76e-06	0.000105	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCL5—atopic dermatitis	7.74e-06	0.000105	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CASP8—atopic dermatitis	7.71e-06	0.000104	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCL5—atopic dermatitis	7.65e-06	0.000103	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GLB1—atopic dermatitis	7.59e-06	0.000103	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—IL2—atopic dermatitis	7.51e-06	0.000101	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PPARA—atopic dermatitis	7.48e-06	0.000101	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—IL6—atopic dermatitis	7.46e-06	0.000101	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1B—atopic dermatitis	7.42e-06	0.0001	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CD4—atopic dermatitis	7.42e-06	0.0001	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—IL2—atopic dermatitis	7.42e-06	0.0001	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL2—atopic dermatitis	7.39e-06	0.0001	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CXCL8—atopic dermatitis	7.35e-06	9.93e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ADSL—atopic dermatitis	7.28e-06	9.83e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCL5—atopic dermatitis	7.24e-06	9.78e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NGF—atopic dermatitis	7.17e-06	9.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CXCL8—atopic dermatitis	7.13e-06	9.64e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NGF—atopic dermatitis	7.08e-06	9.57e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CXCL8—atopic dermatitis	7.05e-06	9.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—IL2—atopic dermatitis	7.02e-06	9.49e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NFKBIA—atopic dermatitis	7.01e-06	9.48e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCR5—atopic dermatitis	6.97e-06	9.42e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NFKBIA—atopic dermatitis	6.95e-06	9.4e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL10—atopic dermatitis	6.94e-06	9.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCR5—atopic dermatitis	6.89e-06	9.31e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL2—atopic dermatitis	6.82e-06	9.22e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—MAPK8—atopic dermatitis	6.81e-06	9.2e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL2—atopic dermatitis	6.74e-06	9.11e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NGF—atopic dermatitis	6.7e-06	9.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCL8—atopic dermatitis	6.67e-06	9.02e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GLB1—atopic dermatitis	6.61e-06	8.94e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IFNG—atopic dermatitis	6.56e-06	8.86e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCR5—atopic dermatitis	6.52e-06	8.81e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	6.4e-06	8.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL2—atopic dermatitis	6.38e-06	8.62e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ADSL—atopic dermatitis	6.34e-06	8.57e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD4—atopic dermatitis	6.33e-06	8.56e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GLB1—atopic dermatitis	6.23e-06	8.42e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GLB1—atopic dermatitis	6.18e-06	8.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.07e-06	8.2e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.03e-06	8.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCL5—atopic dermatitis	5.97e-06	8.08e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ADSL—atopic dermatitis	5.97e-06	8.07e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ADSL—atopic dermatitis	5.92e-06	8e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NFKBIA—atopic dermatitis	5.91e-06	7.99e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—IL6—atopic dermatitis	5.88e-06	7.95e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1B—atopic dermatitis	5.85e-06	7.91e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CD4—atopic dermatitis	5.85e-06	7.9e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NFKBIA—atopic dermatitis	5.84e-06	7.89e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL2—atopic dermatitis	5.83e-06	7.88e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—IL2—atopic dermatitis	5.8e-06	7.84e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL8—atopic dermatitis	5.74e-06	7.76e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NGF—atopic dermatitis	5.53e-06	7.48e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.53e-06	7.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NFKBIA—atopic dermatitis	5.53e-06	7.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.51e-06	7.45e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL2—atopic dermatitis	5.48e-06	7.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL6—atopic dermatitis	5.46e-06	7.38e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCR5—atopic dermatitis	5.38e-06	7.28e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—MAPK8—atopic dermatitis	5.36e-06	7.25e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GLB1—atopic dermatitis	5.28e-06	7.13e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL2—atopic dermatitis	5.26e-06	7.12e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.06e-06	6.85e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ADSL—atopic dermatitis	5.06e-06	6.84e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MAPK8—atopic dermatitis	5.05e-06	6.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL8—atopic dermatitis	5e-06	6.76e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL6—atopic dermatitis	4.99e-06	6.74e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL8—atopic dermatitis	4.96e-06	6.7e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL2—atopic dermatitis	4.78e-06	6.46e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL6—atopic dermatitis	4.76e-06	6.43e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL2—atopic dermatitis	4.74e-06	6.4e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL6—atopic dermatitis	4.71e-06	6.37e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—IL6—atopic dermatitis	4.6e-06	6.22e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.58e-06	6.19e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.56e-06	6.17e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.5e-06	6.08e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MAPK8—atopic dermatitis	4.4e-06	5.95e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARA—atopic dermatitis	4.36e-06	5.9e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MAPK8—atopic dermatitis	4.36e-06	5.89e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL6—atopic dermatitis	4.35e-06	5.88e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL8—atopic dermatitis	4.21e-06	5.7e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL8—atopic dermatitis	4.16e-06	5.63e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.07e-06	5.51e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2—atopic dermatitis	4.03e-06	5.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—atopic dermatitis	4.01e-06	5.42e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—atopic dermatitis	4.01e-06	5.42e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2—atopic dermatitis	3.98e-06	5.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—atopic dermatitis	3.96e-06	5.35e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL8—atopic dermatitis	3.94e-06	5.33e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.93e-06	5.32e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.9e-06	5.28e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.85e-06	5.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2—atopic dermatitis	3.77e-06	5.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—atopic dermatitis	3.75e-06	5.07e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK8—atopic dermatitis	3.71e-06	5.01e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK8—atopic dermatitis	3.66e-06	4.95e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK8—atopic dermatitis	3.47e-06	4.69e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—atopic dermatitis	3.42e-06	4.63e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.25e-06	4.4e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—atopic dermatitis	3.22e-06	4.36e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—atopic dermatitis	3.16e-06	4.27e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—atopic dermatitis	3.11e-06	4.2e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—atopic dermatitis	3.09e-06	4.18e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK8—atopic dermatitis	2.86e-06	3.87e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARA—atopic dermatitis	2.85e-06	3.85e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.84e-06	3.84e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—atopic dermatitis	2.81e-06	3.8e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—atopic dermatitis	2.78e-06	3.76e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARA—atopic dermatitis	2.69e-06	3.63e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARA—atopic dermatitis	2.46e-06	3.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—atopic dermatitis	2.37e-06	3.2e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—atopic dermatitis	2.34e-06	3.16e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—atopic dermatitis	2.21e-06	2.99e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARA—atopic dermatitis	2.15e-06	2.9e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.02e-06	2.73e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARA—atopic dermatitis	2e-06	2.71e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—atopic dermatitis	1.83e-06	2.47e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.71e-06	2.32e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.32e-06	1.79e-05	CbGpPWpGaD
